Similarly, those patients in which the tumor had high PROM1 expression and MGMT was methylated had a longer survival than unmethylated or patients with low expression of PROM1, regardless of MGMT methylation status (Fig. 11). This evidence concerns the gene PROM1 and neoplasm.